Piramal Enterprises looking at re-entry into pharma sector via the acquisition of multiple pharma assets
Piramal Enterprises Ltd (PEL) is scouting the market for multiple acquisition openings across its pharma business. This indicates a possible…
Piramal Enterprises Ltd (PEL) is scouting the market for multiple acquisition openings across its pharma business. This indicates a possible…
Mahindra Group’s chairman Anand Mahindra took to Twitter on Monday to call pharma giant Cipla’s efforts to bring Moderna’s vaccine…
The net profit of drugmaker Glenmark Pharmaceuticals increased by 6 per cent to Rs 233.87 crore during the January-March quarter…